These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4366516)

  • 1. Steroid therapy of multiple myeloma and macroglobulinemia.
    Hoogstraten B
    Med Clin North Am; 1973 Sep; 57(5):1321-30. PubMed ID: 4366516
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenal steroids in the treatment of malignant hematologic disease.
    Cline MJ
    Med Clin North Am; 1973 Sep; 57(5):1203-9. PubMed ID: 4205834
    [No Abstract]   [Full Text] [Related]  

  • 3. Corticosteroid drugs: their role in oncological practice.
    Lowenthal RM; Jestrimski KW
    Med J Aust; 1986 Jan; 144(2):81-5. PubMed ID: 2417096
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone healing in multiple myeloma with melphalan chemotherapy.
    Rodriguez LH; Finkelstein JB; Shullenberger CC; Alexanian R
    Ann Intern Med; 1972 Apr; 76(4):551-6. PubMed ID: 4640313
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of immunoproliferative diseases].
    Quattrin N; Ventruto V; Dini E; Montuori R
    Haematol Lat; 1969; 12(3):743-53. PubMed ID: 4097257
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary hyperparathyroidism in an elderly patient with multiple myeloma.
    Rosen C; Segal H; Hartz CE; Mroz F; Carlton E
    J Am Geriatr Soc; 1992 Jul; 40(7):703-5. PubMed ID: 1318890
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with methyl-benzyl-hydrazine (Natulan) in lymphoreticular diseases and hemoblastoses].
    Schubert JC; Martin H
    Blut; 1968; 18(1):42-7. PubMed ID: 4972003
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination chemotherapy for multiple myeloma with BCNU, cyclophosphamide, vincristine, melphalan, and prednisone (M-2 protocol).
    Case DC; Sonneborn HL; Paul SD; Hayes DM; Dorsk BM; Carroll RJ; Bove L
    Oncology; 1985; 42(3):137-40. PubMed ID: 3858763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of malignant gammopathies].
    Emmerich B
    Dtsch Med Wochenschr; 1984 Jan; 109(1):26-30. PubMed ID: 6420138
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytomorphological, immunochemical and therapeutic aspects of multiple myeloma].
    Maroncelli P; Casalino C
    Minerva Med; 1973 Feb; 64(8):337-57. PubMed ID: 4120544
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of hemoblastoses. V. Plasmocytoma and macroglobulinemic reticulosis of Walderström].
    Danieli G
    G Clin Med; 1967 Feb; 48(2):164-74. PubMed ID: 4971622
    [No Abstract]   [Full Text] [Related]  

  • 12. [Steroid therapy for hematologic diseases--indications and methods of administration].
    Matsumoto N; Miwa S
    Nihon Rinsho; 1979 Jun; 37(6):1302-7. PubMed ID: 384053
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic factors in multiple myeloma.
    Alexanian R; Balcerzak S; Bonnet JD; Gehan EA; Haut A; Hewlett JS; Monto RW
    Cancer; 1975 Oct; 36(4):1192-201. PubMed ID: 1175123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experience on the use of l-phenylalanin nitrogen mustard (melphalan)].
    Artigas L; Dondo Lascano F; Seoane MR; Sagasta C
    Prensa Med Argent; 1970 Mar; 57(3):142-8. PubMed ID: 4989273
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of myeloma. Comparison of melphalan, chlorambucil, and azathioprine.
    Arch Intern Med; 1975 Jan; 135(1):157-62. PubMed ID: 1111464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cell myeloma. An interpretive review.
    Bergsagel DE
    Cancer; 1972 Dec; 30(6):1588-94. PubMed ID: 4565818
    [No Abstract]   [Full Text] [Related]  

  • 17. [Humoral immune deficiency in paraproteinemias].
    Mordasini RC; Keller H; Schlumpf E; Riva G
    Schweiz Med Wochenschr; 1972 May; 102(18):625-35. PubMed ID: 4624420
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of multiple myeloma and macroglobulinemai Waldenström: A long-term follow-up study.
    Onodera S; Otaki M; Oikawa K; Mikami M; Sato I
    Tohoku J Exp Med; 1975 Aug; 116(4):317-25. PubMed ID: 810919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vindesine therapy in melphalan-resistant multiple myeloma.
    Houwen B; Ockhuizen T; Marrink J; Nieweg HO
    Eur J Cancer (1965); 1981 Feb; 17(2):227-32. PubMed ID: 7262159
    [No Abstract]   [Full Text] [Related]  

  • 20. [Corticotherapy in infantile hematology].
    Paolucci G; Rosito P
    Minerva Pediatr; 1969 Oct; 21(43):1989-2005. PubMed ID: 4326806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.